"Merchants of Medicine: Nostrum Peddlers-Yesterday & Today"from Drukker Press is described by the author as "an imaginary museumof treasures." The new book discusses urologic nostrums and the hucksterswho sold them over the years.
Prostate cancer genomic tests show prognostic value for progression, therapy benefit
April 22nd 2024"This preplanned ENACT trial biomarker analysis demonstrates the value of the Decipher score, AR-A score, and PAM50 genomic classifiers in identifying patients undergoing AS who are most likely to benefit from enzalutamide treatment," wrote the authors.